Vitamin C Cancer Care
High-dose vitamin C IV therapy provides a perfect harmony in fighting cancer. It is beneficial to the healthy cells of the body, while killing the cancerous cells. Vitamin C (also known as ascorbate) in high doses causes the production of hydrogen peroxide in cells. This allows high-dose vitamin C IV therapy to take advantage of a key characteristic of cancerous cells.
Cancer cells do not use oxygen to breakdown glucose for energy, and therefore have very small amounts of an enzyme called catalase. Catalase is present in healthy cells and works to break down hydrogen peroxide into water and oxygen, promoting healthy cell function. However, due to cancer cells lacking catalase, when given vitamin C (ascorbate) in high doses, they are unable to breakdown the hydrogen peroxide, become oxidized, and undergo cell death.
High-dose vitamin C IV therapy is a targeted natural therapy to that can
be used to fight cancer as well as various infections.
High-dose vitamin C IV therapy is now recognized by various national organizations such as the National Institute of Health (NIH) and the National Cancer Institute.
Clinical Research Studies
Additionally, there has been a variety of clinical research studies performed illustrating the positive effects that high-dose vitamin C IV therapy has on improving cancer patients quality of life, as well as extending their lives.
Schoenfeld, J. D., Sibenaller, Z. A., Mapuskar, K. A., Wagner, B. A., Cramer-Morales, K. L., Furqan, M., … Allen, B. G. (2017). O2; and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate. Cancer Cell, 31(4), 487–500.e8.https://doi.org/10.1016/j.ccell.2017.02.018
Chen, Q., Espey, M. G., Krishna, M. C., Mitchell, J. B., Corpe, C. P., Buettner, G. R., ... & Levine, M. (2005). Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues. Proceedings of the national academy of sciences of the United States of America, 102(38), 13604-13609.